NCT02106325View on ClinicalTrials.gov

Ketamine as a Rapidly-Acting Antidepressant in Depressed Emergency Department Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

February 29, 2016

Study Completion Date

March 31, 2017

Conditions
Depression
Interventions
DRUG

Ketamine

IV of Ketamine (.25mg/kg)

DRUG

Diphenhydramine

Intravenous Diphenhydramine (25mg) at the time of presentation to Emergency Department

Trial Locations (2)

10016

Bellevue Hospital Center, New York

NYU Langone Medical Center/Tisch Hospital, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT02106325 - Ketamine as a Rapidly-Acting Antidepressant in Depressed Emergency Department Patients | Biotech Hunter | Biotech Hunter